Skip to main
  1. Stocks
  2. Inspire Medical Systems Inc
  3. Forecast
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 19%
Hold 56%
Sell 6%
Strong Sell 6%

Bulls say

Inspire Medical Systems is viewed positively because 3Q26 results showed the core U.S. business reaccelerating, with U.S. revenue up 5% sequentially and total revenue of $207M beating estimates while adjusted EBITDA of $38M and EPS of $0.14 also exceeded expectations. Management’s initial 2027 guidance for low-single-digit revenue growth appears prudently conservative given easing coding and reimbursement headwinds, a final 2027 CMS rate increase for CPT 64582 in facility fees, and growth support from pulse generator replacements and incremental commercial investment funded by Project Horizon savings. The stock also looks attractive fundamentally because shares trade at about a 50% discount to peers on EV/2026 EBITDA and a roughly 33% discount to its own two-year median, despite a strong balance sheet with net cash above 25% of market cap and robust free cash flow generation.

Bears say

Inspire Medical Systems is facing a weakening fundamental backdrop as growth is expected to decelerate and even decline in 2026 amid coding and reimbursement frictions that are limiting profitability expansion. The 1Q guidance cut reduced confidence in management’s ability to outperform expectations, with reimbursement and coding confusion clouding visibility on demand and procedure economics. Additional pressure comes from the risk of earlier-than-expected competitive neurostimulation entrants, alternative OSA treatments, weight-loss drugs shrinking the addressable market, and possible delays or setbacks in the INSP V launch.

INSP has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 19% recommend Buy, 56% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

INSP Analyst Forecast & Price Prediction

Get the latest INSP stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in INSP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 16 analysts, INSP has a Hold consensus rating as of Nov 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $80.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $80.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


INSP Analyst Forecast & Price Prediction

Get the latest INSP stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in INSP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover INSP stock data and trends